Encouraged by these data, we then sought to demonstrate α-C-H cyanation as an avenue for late-stage functionalization. To this end, several biologically active substrates (drug APIs) containing tertiary amine moieties were employed as substrates (Scheme 4). Excitingly, every complex structure tested afforded the desired cyanated product(s) in at least 51% assay yield (44% isolated yield).